צמיחת רווחי EPS רבעונית LakeShore Biopharma Co. (LSB)
LakeShore Biopharma Co. (LSB) is developing a Chinese network for the production of anti-rabies drugs, utilizing GMP lines for government procurement. Changes in quarterly EPS dynamics illustrate profit momentum, where the -168.50 metric determines the parameter status. Modern plants in China guarantee stability, while current vaccine sales provide the base cash flow as the market awaits the results of Phase III trials for new developments.
%20%D7%A6%D7%9E%D7%99%D7%97%D7%AA%20%D7%A8%D7%95%D7%95%D7%97%20%D7%A0%D7%A7%D7%99%20%D7%9C%D7%9E%D7%A0%D7%99%D7%94%20%D7%9E%D7%A9%D7%A0%D7%94%20%D7%9C%D7%A9%D7%A0%D7%94%20%D7%91-12%20%D7%94%D7%97%D7%95%D7%93%D7%A9%D7%99%D7%9D%20%D7%94%D7%90%D7%97%D7%A8%D7%95%D7%A0%D7%99%D7%9D&width=1200&height=400&colorIndex=0&v=mwczyyub.rjb-7czcsu8&start=20220704&end=20261112&filename=GURU_Markets_-_LSB_-_LakeShore-Biopharma-Co._-_Year-over-year-net-earnings-per-share-growth-for-the-last-12-months "צמיחת רווח נקי למניה משנה לשנה ב-12 החודשים האחרונים YS Biopharma Co., Ltd. (LSB): לתקופה 29.05.2024 - 04.10.2025 | 👁️GURU.Markets👁️")
פילוחים אנליטיים של חברת LakeShore Biopharma Co.
Quarterly earnings per share (EPS) growth measures the rate of change in net income attributable to a single common share, allowing for an assessment of the business's real operational efficiency over time. By analyzing EPS dynamics over a quarterly period on the GURU.Markets platform, an investor can see how LakeShore Biopharma Co. (LSB) expenditures on environmental modernization and ESG optimization impact the asset's final yield.
